Skip to main content
logo
Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
18.51
+0.02 (0.11%)
Sep 2, 2026, 4:00 PM EDT - Market closed

Relay Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4,0561,4666901,3571,8063,318
Market Cap Growth
555.35%112.63%-49.19%-24.86%-45.56%-11.11%
Enterprise Value
3,176903-1006018132,725
Last Close Price
18.518.464.1211.0114.9430.71

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
391.9195.4968.9153.131307.871095.42
PB Ratio
4.542.590.891.811.903.70
P/TBV Ratio
4.562.590.891.811.913.71

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
306.8658.82-23.53588.46899.58

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.060.060.070.060.03
Net Debt / Equity Ratio
-0.99-0.92-0.94-0.93-0.99-1.04
Net Debt / EBITDA Ratio
2.861.761.931.863.074.21
Net Debt / FCF Ratio
4.152.212.922.293.9512.01
Asset Turnover
0.010.020.010.030.000.00
Quick Ratio
17.9321.6815.4024.7815.7639.60
Current Ratio
18.2722.6115.9525.4416.0040.14
Return on Equity (ROE)
-36.77%-41.12%-44.15%-40.18%-31.44%-43.81%
Return on Assets (ROA)
-22.88%-25.16%-28.11%-24.40%-18.44%-15.63%
Return on Capital Employed (ROCE)
-33.90%-50.40%-47.00%-46.60%-30.00%-23.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.05%-18.86%-48.97%-25.20%-16.08%-10.97%
FCF Yield
-5.23%-16.09%-36.41%-22.43%-13.21%-2.35%
Buyback Yield / Dilution
-12.39%-20.10%-16.55%-9.21%-17.97%-123.22%
SEC Filings: 10-K · 10-Q